Initiation of Pharmacokinetics Pk Modeling for Antibody and More Advanced Targeted Therapy

  • Action. Assessment of feasibility of biotherapeutics group’s hypothesis whether Meditope platform is efficient for antibody recycling compared to ADC platform by building a minimal Pharmacokinetics (PK) model by integrating literature data.
  • Result. Provided hypothesis assessment result by quantiative modeling, which turned out compatible proof-of-concept to later Meditope experiment result.
  • Computing. Python (NumPy/SciPy)

Presentation

Integrated Bioinformatics Tool De Novo Tags Assembly for Antibody Sequence Reconstruction